SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001566044-20-000009
Filing Date
2020-08-06
Accepted
2020-08-06 07:11:52
Documents
16
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlo-20200806.htm   iXBRL 8-K 41617
2 EX-99.1 mnlo-2020086q2xexx991.htm EX-99.1 350230
8 menlotherapeutics211.jpg GRAPHIC 122589
  Complete submission text file 0001566044-20-000009.txt   728850

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlo-20200806.xsd EX-101.SCH 2547
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlo-20200806_cal.xml EX-101.CAL 821
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlo-20200806_def.xml EX-101.DEF 1785
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlo-20200806_lab.xml EX-101.LAB 25280
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlo-20200806_pre.xml EX-101.PRE 13298
9 EXTRACTED XBRL INSTANCE DOCUMENT mnlo-20200806_htm.xml XML 11828
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 201079779
SIC: 2834 Pharmaceutical Preparations